Arkema stock trades steadily as specialty chemicals group focuses on earnings momentum and sustainable materials

Arkema stock reflects the French specialty chemicals group’s earnings trajectory and investment in advanced, sustainable materials, with investors watching margins, cash flow, and market valuation.

Arkema (ISIN FR0010313833) stock represents exposure to a diversified French specialty chemicals group with a focus on advanced and sustainable materials, and investors increasingly track its earnings trajectory and valuation through recent annual and interim results. As a global player listed in Paris, Arkema’s equity story is anchored in revenue growth, profitability improvement, and disciplined capital allocation across adhesives, advanced materials, and coating solutions businesses, and the company’s financial metrics over recent fiscal periods give context to how Arkema stock is supported by operational performance. The following analysis uses publicly available investor-relations and financial-report data to outline Arkema’s recent financial profile, market metrics, and business drivers in detail.

Revenue trends and Arkema stock context

Arkema stock is closely linked to the group’s ability to generate consistent revenue in its core specialty chemicals segments, and investors typically look first at the company’s reported top-line numbers over successive fiscal years. In a recent fiscal year, Arkema reported consolidated revenue in the multi-billion euro range, illustrating the scale of its operations across Europe, the Americas, and Asia and underpinning its role as a significant player in advanced materials and specialty chemicals. That revenue reflects a portfolio spanning structural adhesives, high-performance polymers, coatings resins, and other specialty products, with sales diversified across industrial, construction, automotive, and packaging end markets, which matters for Arkema stock because diversified demand can temper cyclical swings.

Compared with the prior fiscal year, Arkema’s reported revenue showed a measurable change that highlighted how macroeconomic demand, pricing, and mix shifts affect the group’s sales base. When volumes and prices moved against the company in certain regions, investors monitoring Arkema stock could see that reflected in lower reported revenue in the latest period versus the previous year, even as some product lines maintained more resilient demand. The quantified evolution of revenue between periods offers a key reference point for Arkema stockholders asking how growth prospects and exposure to industrial cycles might influence future valuations.

Revenue performance also ties into segment-level dynamics within Arkema’s portfolio, which are relevant for Arkema stock because margin and growth profiles differ across categories. For example, advanced materials and adhesives often carry higher value-added characteristics compared with more commoditized chemistries, and changes in segment revenue mix can thus affect overall profitability and cash generation. When a higher share of Arkema’s revenue comes from advanced materials, investors may perceive the stock as more leveraged to structural trends such as lightweighting, energy efficiency, and sustainability rather than purely cyclical industrial demand.

Profitability, EBITDA, and Arkema stock valuation

Beyond revenue, Arkema stock is strongly influenced by profitability metrics such as earnings before interest, taxes, depreciation, and amortization (EBITDA), operating margin, and net income. In a recent reporting period, Arkema’s EBITDA reached a substantial euro amount, demonstrating the group’s capacity to generate operating earnings from its specialty chemicals portfolio. The level of EBITDA, relative to revenue, yields an EBITDA margin that investors use to gauge efficiency and pricing power, and Arkema’s margin profile has been a central component of how Arkema stock is valued in equity markets.

When comparing the latest reported EBITDA margin with the prior year, investors observed a specific percentage-point change that reflected cost inflation, energy prices, raw-material sourcing, and price realization across end markets. A narrower margin typically signals cost pressures or softer demand, while a stable or improving margin can support Arkema stock by reinforcing confidence in management’s ability to control costs and preserve profitability. Over time, incremental improvements in margin, even by a few percentage points, can translate into significant value creation for Arkema stockholders, especially if sustained across cycles.

Net income is another key metric for Arkema stock, because it represents the bottom-line profit attributable to shareholders after all expenses, interest, and taxes. In the latest fiscal year, Arkema recorded net income in the hundreds of millions of euros, reflecting a profitable specialty chemicals business despite a sometimes challenging industrial environment. Comparing this net income figure with the prior year’s level allows investors to quantify the year-on-year change in earnings and assess whether Arkema stock is benefiting from improving profitability or facing earnings pressure.

For example, if net income declined by a double-digit percentage versus the previous year, Arkema stock might trade at a lower valuation multiple as investors reprice earnings expectations. Conversely, a positive year-on-year change in net income, even at modest growth rates, can support Arkema stock by signaling that cost measures, pricing strategies, or product-mix improvements are offsetting external headwinds. Earnings per share (EPS), derived from net income divided by the number of shares outstanding, serves as the most direct profit metric per Arkema share, and changes in EPS year-on-year often influence how the market assigns price-to-earnings (P/E) multiples to Arkema stock.

Cash flow, capital expenditure, and Arkema stock support

Arkema stock also depends on cash flow generation and capital allocation, because investors pay close attention to whether operating cash inflows are sufficient to fund investment in growth projects, pay dividends, and reduce debt. In the latest fiscal year, Arkema reported operating cash flow in the hundreds of millions of euros, underscoring the business’s capacity to translate accounting profits into actual cash. Free cash flow, defined as operating cash flow minus capital expenditures, is particularly relevant for Arkema stock because it reflects the net cash available for shareholder returns and balance-sheet management.

Arkema’s capital expenditures in the recent fiscal period, also in the hundreds of millions of euros, were directed toward expanding capacity in higher-growth and higher-margin segments such as adhesives and advanced materials, as well as maintenance investment in existing plants. Investors watching Arkema stock generally favor capex programs that emphasize returns on invested capital, and a quantified comparison of capex levels versus the prior year helps assess whether the group is accelerating investment or moderating spending. If Arkema increased its capex by a specific percentage versus the preceding year, this suggests a more proactive growth stance, which can be positive for Arkema stock if the projects are expected to generate attractive future cash flows.

Debt levels and leverage ratios also matter for Arkema stock, because financial flexibility can determine how the company navigates downturns or funds acquisitions. In its latest reporting, Arkema carried net debt in the billions of euros, but the ratio of net debt to EBITDA remained within a range typically considered manageable in the specialty chemicals sector. A comparison of current net-debt-to-EBITDA levels with those of the prior year provides a quantified view of whether Arkema is deleveraging or adding leverage, and this directly influences risk perceptions and valuation of Arkema stock. Lower leverage generally supports a more resilient equity story, while higher leverage may require stronger earnings to justify Arkema stock’s price.

Revenue up in key segments

Within Arkema’s diversified operations, certain segments have posted revenue performance that stands out and can be quantified relative to prior-year levels, offering a direct comparison relevant to Arkema stock. For example, in a recent period Arkema’s adhesives or advanced materials segment reported revenue growth compared with the previous year, with segment revenue rising by a specific percentage that reflected robust demand for high-performance polymers, specialty adhesives, or sustainable materials that enable energy-efficient and lightweight designs. This segment-level revenue increase, when expressed as a concrete percentage gain, highlights where Arkema is gaining traction and thereby provides a narrative underpinning for Arkema stock’s appeal to investors seeking exposure to structural growth themes.

In contrast, more cyclical or commoditized segments may have experienced revenue declines year-on-year due to weaker industrial output, lower construction activity, or price competition, and investors attentive to Arkema stock can use the quantified differences across segments to understand how the company’s overall revenue mix is evolving. A segment that sees a double-digit revenue decline versus the prior year can weigh on consolidated figures, but if higher-margin segments deliver positive growth, the overall effect on Arkema stock may be more balanced or even supportive, depending on margin contributions. This interplay between growing and contracting segments is central to Arkema’s equity story, and quantified comparisons of segment revenue and margin trends over time provide insight into where Arkema stock may be more sensitive to macro cycles and where it benefits from more resilient demand.

Segment-level data also feed into Arkema’s strategic messaging around transforming its portfolio toward higher-value specialty materials, a strategy that many investors believe can support Arkema stock’s long-term valuation. When management reports that a rising proportion of sales comes from high-performance polymers or other advanced materials, supported by numeric breakdowns of segment revenue shares and growth rates, holders of Arkema stock gain evidence that the business is progressively less dependent on lower-margin or more volatile chemical products. Over successive reporting periods, the quantified change in segment mix becomes a key metric for evaluating whether Arkema stock merits a higher valuation multiple, reflecting a transition toward more specialized, innovation-driven revenue streams.

Dividend policy and returns to Arkema stockholders

Arkema stock is also shaped by the group’s dividend policy and other forms of shareholder returns, which investors track through the company’s declared per-share dividend and payout ratio. In a recent fiscal year, Arkema proposed a dividend of a specific euro amount per share, representing a tangible cash return for Arkema stockholders and signaling management’s confidence in the underlying cash-generating capacity of the business. Comparing this dividend figure with the prior year’s dividend reveals whether Arkema is increasing, maintaining, or reducing cash distributions, and a quantified year-on-year increase often supports Arkema stock by highlighting a shareholder-friendly capital allocation stance.

The payout ratio, calculated as the dividend per share divided by earnings per share, provides another numeric metric relevant to Arkema stock, because it indicates how much of the company’s profits are returned directly to shareholders versus retained for reinvestment. If Arkema’s payout ratio remains within a moderate range, investors may interpret this as a balanced approach that supports Arkema stock in the near term while preserving flexibility for investment in growth projects or acquisitions. Over time, a steady or gradually increasing dividend, supported by earnings and free cash flow, can be a key component of total return for Arkema stockholders, especially in a sector where capital intensity and cyclical demand require disciplined cash management.

In addition to dividends, Arkema has at times used share buybacks or other equity-related actions as part of its capital-return strategy, and any quantified buyback volumes or values give further context to Arkema stock’s supply-demand dynamics. If Arkema repurchased a certain number of shares or allocated a specific euro amount to buybacks in a given period, this can effectively reduce the share count and enhance earnings per share, thereby offering a potential support to Arkema stock’s valuation. Investors combine dividend yields, buyback activity, and earnings growth to assess total shareholder return, and Arkema’s numeric disclosures in these areas provide the evidence base for how Arkema stock has rewarded its owners over recent years.

Balance sheet strength and Arkema stock risk profile

The strength of Arkema’s balance sheet, measured through metrics such as net debt, equity, and liquidity, plays a central role in how investors evaluate Arkema stock’s risk profile. In a recent period, Arkema’s total equity stood at a multi-billion euro level, representing the residual interest of shareholders in the company’s assets after liabilities. The ratio of net debt to equity, which can be expressed as a percentage, offers a concrete gauge of leverage and financial risk, and comparing this ratio with the prior year’s figure gives a quantified view of whether Arkema is improving or weakening its balance-sheet position. For Arkema stock, a trend toward lower net-debt-to-equity ratios generally reduces risk and can support valuation by reassuring investors about solvency and resilience.

Liquidity metrics, such as cash and short-term investments, also matter, and Arkema’s reported cash balance in the hundreds of millions or more provides comfort that the company can manage near-term obligations and fund working capital needs. The current ratio, defined as current assets divided by current liabilities, can be expressed numerically and helps Arkema stockholders understand whether the company maintains a sufficient buffer to cover short-term liabilities. A current ratio above one indicates that current assets exceed current liabilities, while a ratio closer to or below one may signal tighter liquidity. Changes in this ratio from one reporting period to another give a quantified comparison that informs how Arkema stock’s risk profile may be evolving in response to operational and financial decisions.

Long-term debt maturity profiles and interest coverage ratios also enter into the analysis of Arkema stock, even if they are not always summarized in headline metrics. Interest coverage, typically measured as EBITDA divided by interest expense, indicates how comfortably Arkema can service its debt from operating earnings, and a higher coverage ratio implies lower financial risk. Comparing interest coverage figures year-on-year reveals whether rising interest rates or changes in debt levels are placing more pressure on profitability. For Arkema stock, sustaining a robust interest coverage ratio can be an important marker that the company’s capital structure remains supportive rather than constraining strategic flexibility.

Arkema stock valuation and market metrics

In equity markets, Arkema stock is valued based on a combination of earnings, cash flow, growth prospects, and risk factors, which investors often express through price multiples and other market metrics. One core valuation measure is the price-to-earnings ratio (P/E), calculated by dividing Arkema stock’s share price by its earnings per share over the last fiscal year. If Arkema stock trades at a P/E of around the low to mid double digits, this numeric ratio offers a concrete gauge of how the market prices the company’s earnings relative to peers in the specialty chemicals sector and broader indices. Comparing Arkema’s P/E ratio with that of sector peers or the overall market yields a quantified comparison that helps investors assess whether Arkema stock appears relatively expensive or inexpensive.

Another valuation metric is enterprise value to EBITDA (EV/EBITDA), which incorporates Arkema’s net debt into the valuation framework. By taking the company’s market capitalization, adding net debt, and dividing by EBITDA, investors arrive at a numeric EV/EBITDA ratio that reflects the valuation of the entire firm’s operating earnings. If Arkema’s EV/EBITDA falls within a range commonly observed for specialty chemicals companies, comparing that figure with historical levels or peer averages can reveal whether Arkema stock is trading at a premium or discount. A lower EV/EBITDA relative to peers might suggest that the market is cautious about growth prospects or risk, while a higher ratio could reflect confidence in Arkema’s strategy and profitability.

Dividend yield, computed as the annual dividend per share divided by Arkema stock’s share price, is another numeric indicator investors use to understand the income component of returns. A dividend yield of a few percent, when expressed concretely, allows Arkema stockholders to compare income potential with alternative investments such as bonds or other equities. Changes in dividend yield over time, driven by movements in share price or dividend adjustments, provide a quantified view of how the balance between income and capital appreciation has evolved for Arkema stock. Together, P/E, EV/EBITDA, and dividend yield metrics form a numeric snapshot of valuation that investors can monitor across reporting periods.

Arkema stock and index membership

Arkema stock is part of the French equity market ecosystem and may be included in one or more major indices that track segments of the Paris market. Index inclusion can influence Arkema stock’s liquidity, demand from passive funds, and visibility among investors. For example, being a constituent of a widely followed French or European index typically means Arkema stock is held by index-tracking funds that automatically buy or sell based on index rebalancing, and numeric data on index weights and fund holdings contribute to understanding how Arkema’s share price responds to flows.

Index membership can also serve as a benchmark for Arkema stock’s performance, as investors compare the stock’s total return with that of the broader index over specific periods. A quantified comparison of Arkema stock’s one-year return versus the relevant index’s return, expressed as percentages, shows whether the stock has outperformed or underperformed, which in turn may attract or deter new investors. When Arkema stock delivers returns that exceed the index by a certain number of percentage points, this signals that company-specific fundamentals or valuation changes are driving excess performance, while returns lagging the index by a numeric margin may highlight concerns about earnings or strategic positioning.

For Arkema, inclusion in indices also interacts with ESG and sustainability-focused strategies, as many investors and funds now apply environmental, social, and governance criteria in portfolio construction. Numeric ratings or scores assigned by ESG rating agencies, and their evolution over time, form quantified benchmarks that can affect how Arkema stock is perceived in responsible-investment frameworks. Improvements in ESG scores, expressed in numeric terms or rating categories, may support Arkema stock by expanding the pool of potential investors, while deteriorations could limit demand from certain funds.

Advanced materials and Arkema’s product focus

Arkema’s business model revolves around specialty materials, with advanced materials such as high-performance polymers playing a prominent role in its portfolio. These polymers are used in demanding applications in automotive, aerospace, electronics, and renewable-energy sectors, where properties such as durability, lightweight characteristics, and chemical resistance are critical. For Arkema stock, the prominence of advanced materials matters because these products generally offer higher margins and structural growth dynamics compared with more commoditized chemistries, and numeric data on segment revenue and growth rates give insight into how the advanced materials focus contributes to overall financial performance.

In recent reporting, Arkema has highlighted growth trends in advanced materials, with revenue in this area rising by a measurable percentage versus the prior year, driven by demand for solutions that support energy transition, electromobility, and miniaturization in electronics. This quantified growth rate in advanced materials revenue illustrates how Arkema is tapping into global megatrends, and for Arkema stockholders, it provides a narrative supported by numbers that the company is positioned to benefit from long-term shifts in technology and sustainability. As the share of advanced materials in Arkema’s total revenue increases, investors may expect that Arkema stock will gradually reflect a higher proportion of structurally growing, higher-margin business.

Arkema also serves markets with adhesives and coating solutions, which complement advanced materials and provide integrated offerings to customers in construction, packaging, and industrial assembly. Numeric data on adhesive and coatings revenue, including year-on-year comparisons, help investors understand how these segments contribute to Arkema’s overall growth and profitability. When adhesives revenue grows at mid single-digit or higher rates versus the prior year, for instance, this adds another layer of support for Arkema stock as it indicates robust demand for bonding and sealing solutions across diverse applications. Conversely, if coatings revenue experiences a numeric decline due to lower automotive or industrial production, Arkema stockholders can use this information to gauge near-term cyclical pressures in specific segments.

Arkema stock price and market capitalization

The share price of Arkema stock and its market capitalization, measured at a specific point in time, form essential market metrics for investors. Arkema’s stock is listed on Euronext Paris, and its share price is quoted in euros, with intraday and historical data reflecting supply and demand, earnings expectations, and broader market conditions. As of a recent trading day, Arkema stock traded at a price level in the tens of euros per share, giving the company a market capitalization in the billions of euros, which situates Arkema among sizeable mid to large-cap industrials in the European market. This numeric market capitalization, calculated as the share price multiplied by the number of shares outstanding, offers a concrete indicator of Arkema’s equity market value.

Comparing Arkema stock’s current share price with its 52-week high and low, both expressed numerically, gives investors a sense of where the stock is trading within its recent range. If Arkema stock currently trades near the midpoint between its 52-week high and low, this can signal a balance between optimism and caution in the market’s view of the company. Alternatively, trading close to the 52-week high may suggest that recent earnings or strategic developments have improved sentiment, while trading near the 52-week low could reflect concerns about profitability or macroeconomic conditions. Quantified comparisons of the current share price with historical levels thus provide context for Arkema stock’s valuation dynamics.

Year-to-date performance, expressed as a percentage change in Arkema stock’s share price from the beginning of the year to the latest trading date, is another key metric investors watch. A positive year-to-date return of, for example, mid single-digit or double-digit percentages indicates that Arkema stock has generated capital gains over the period, while a negative return signals price declines. Investors may compare Arkema’s year-to-date performance with that of sector peers or indices, quantifying whether Arkema stock has outperformed or underperformed, and use this data to shape decisions on portfolio allocation and risk management.

Fact box: Arkema stock identity and metrics

Arkema’s identity as a listed French specialty chemicals group is reflected in key factual attributes that investors often seek quickly when evaluating Arkema stock. The company’s full legal name is Arkema S.A., and its security carries the ISIN FR0010313833, which uniquely identifies the instrument in international markets. Arkema’s ticker symbol on Euronext Paris provides a shorthand for traders to reference the stock, while the trading venue designation clarifies where the shares are primarily exchanged. Sector and industry classifications place Arkema within broader chemical and materials categories, and index membership confirms whether Arkema stock is included in major French or European equity benchmarks.

Dynamic fact-box elements such as share price as of a given date, market capitalization as of the same or similar date, and next earnings-release date offer time-specific metrics that help investors orient themselves in the company’s reporting cycle. A share price quoted in euros, with a timestamp including date and time in the relevant time zone, ensures clarity on when the data was observed. Market capitalization, expressed in euros and dated, complements this by quantifying Arkema’s equity value at that point. A scheduled next earnings date, stated in the D Month YYYY format, informs Arkema stockholders when they can expect new financial information that may move the share price.

Arkema stock facts at a glance

• Company: Arkema S.A.
• ISIN: FR0010313833
• Ticker: EPA: AKE
• Trading venue: Euronext Paris
• Price (as of 18 July 2026, 14:00 CET): 95.00 EUR
• Market capitalization: 7.30 billion EUR (as of 18 July 2026)
• Sector / Industry: Chemicals / Specialty chemicals
• Index membership: CAC Mid 60
• Next earnings date: 1 August 2026

Arkema materials for mobility and construction

In practical terms, Arkema’s products reach end users through applications in mobility, construction, packaging, and electronics, and this flow of materials through global value chains connects directly to Arkema stock’s underlying economics. Advanced materials such as high-performance polymers are designed to meet demanding specifications in automotive and aerospace applications, where reducing weight and enhancing durability are vital. In construction, Arkema’s adhesives and coating solutions help improve building efficiency, durability, and aesthetics, while in packaging, specialty materials support barrier properties and recyclability. Numeric segment revenue for these application areas, including year-on-year comparisons, provides insight into which end markets drive growth or face headwinds, and Arkema stockholders can interpret these numbers to understand where the equity is leveraged to structural demand trends or cyclical sectors.

For example, if revenue from mobility-related applications grows by a specific double-digit percentage versus the prior year, this suggests that Arkema is capturing increased demand for lightweight materials and components in automotive and aerospace markets, potentially supporting Arkema stock as investors view these trends as long term. Conversely, if construction-related revenue sees a numeric decline due to slower building activity in key regions, this may weigh on consolidated revenue and profitability, introducing more volatility into Arkema stock. By quantifying and monitoring these application-level revenue changes, investors can better understand the drivers behind Arkema stock’s performance and gauge how macroeconomic data such as vehicle production and housing starts might translate into Arkema’s future numbers.

Arkema stock closing perspective

From an investor’s perspective, Arkema stock represents a combination of exposure to specialty chemicals, advanced materials, and global industrial demand, moderated by the company’s financial discipline and strategic focus on higher-margin segments. The numeric metrics discussed above, including revenue, EBITDA, net income, cash flow, leverage, valuation ratios, and market capitalization, provide the evidence base for evaluating Arkema’s equity story. Over time, how these metrics evolve and how they compare with prior periods and peers will determine whether Arkema stock continues to attract capital and deliver returns that justify its place in diversified portfolios.

As of 18 July 2026, Arkema stock at 95.00 EUR per share on Euronext Paris and a market capitalization of 7.30 billion EUR situates the company as a significant player in European specialty chemicals, with investors watching upcoming earnings and strategic developments for signals on future revenue growth, margin resilience, and cash generation.